Risks of lynch syndrome cancers for msh6 mutation carriers

Journal of the National Cancer Institute

Volumn 102, Issue 3, 2010, Pages 193-201

  Baglietto, Laura ^a   Lindor, Noralane M ^a   Dowty, James G ^c   White, Darren M ^b   Wagner, Anja ^d   Gomez Garcia, Encarna B ^e   Vriends, Annette H J T ^f,g   Cartwright, Nicola R ^h   Barnetson, Rebecca A ^h   Farrington, Susan M ^h   Tenesa, Albert ^h   Hampel, Heather ⁱ   Buchanan, Daniel ^k   Arnold, Sven ^k   Young, Joanne ^k   Walsh, Michael D ^k   Jass, Jeremy ^l,m   MacRae, Finlay ⁿ   Antill, Yoland ^o   Winship, Ingrid M ^n,p   Giles, Graham G ^a   Goldblatt, Jack ^q   Parry, Susan ^r   Suthers, Graeme ^s,u   Leggett, Barbara ^t   Butz, Malinda ^b   Aronson, Melyssa ^u   Poynter, Jenny N ^v   Baron, John A ^w   Le Marchand, Loic ^x   Haile, Robert ^v   Gallinger, Steve ^a   Hopper, John L ^c   Potter, John ^y   De La Chapelle, Albert ^j   Vasen, Hans F ^f   Dunlop, Malcolm G ^h   Thibodeau, Stephen N ^b   Jenkins, Mark A ^c   more..

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h WESTERN GENERAL HOSPITAL   (United Kingdom)

ⁱ Human Cancer Genetics Program   (United States)

^j OHIO STATE UNIVERSITY   (United States)

^k QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m ST MARK S HOSPITAL   (United Kingdom)

ⁿ ROYAL MELBOURNE HOSPITAL   (Australia)

^o PETER MACCALLUM CANCER CENTRE   (Australia)

^p UNIVERSITY OF MELBOURNE   (Australia)

^q UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^r MIDDLEMORE HOSPITAL   (New Zealand)

^s WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^t ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^u MOUNT SINAI HOSPITAL   (Canada)

^v UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^w DARTMOUTH MEDICAL SCHOOL   (United States)

^x UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^y Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MSH6;

AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; ENDOMETRIUM CANCER; FAMILIAL CANCER; FAMILY HISTORY; FAMILY RELATION; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POLYPECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRALIA; CANADA; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; EUROPE; FEMALE; GENE DELETION; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NEOPLASMS; NEW ZEALAND; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; UNITED STATES;

EID: 76349108011     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp473     Document Type: Article

References (38)

1. Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol. 2006;12(31):4943-4950.
2. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999;81(2):214-218.
3. Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary nonpolyposis cancer). J Med Genet. 2007;44(6):353-362.
4. Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23(27):6524-6532.
5. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18): 1851-1860.
6. Barnetson RA, Tenesa A, Farrington SM, et al. Identifcation and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354(26):2751-2763.
7. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among colorectal cancer patients [published online ahead of print September 22, 2008]. J Clin Oncol. 2008;26(35):5783-5788.
8. Berends MJ, Wu Y, Sijmons RH, et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol. 2003;21(23):4364-4370.
9. Hampel H, Frankel W, Panescu J, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006;66(15):7810-7817.
10. Hampel H, Panescu J, Lockman J, et al. Comment on: screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among en-dometrial patients. Cancer Res. 2007;67(19):9603.
11. Devlin LA, Graham CA, Price JH, Morrison PJ. Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts. Ulster Med J. 2008;77(1):25-30.
12. Lu KH, Schorge JO, Rodabaugh KJ, et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol. 2007;25(33):5158-5164.
13. Hendriks YM, Wagner A, Morreau H, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology. 2004;127(1):17-25.
14. Plaschke J, Engel C, Kruger S, et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol. 2004;22(22):4486-4494.
15. Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Gronberg H. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Clin Genet. 2005;68(6):533-541.
16. Wagner A, Hendriks Y, Meijers-Heijboer EJ, et al. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet. 2001;38(5):318-322.
17. Buttin BM, Powell MA, Mutch DG, et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet. 2004;74(6):1262-1269.
18. Chen S, Wang W, Lee S, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA. 2006;296(12):1479-1487.
19. Carayol J, Khlat M, Maccario J, Bonaiti-Pellie C. Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet. 2002;39(5):335-339.
20. Jenkins MA, Baglietto L, Dowty JG, et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol. 2006;4(4):489-498.
21. Newcomb PA, Baron J, Cotterchio M, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2331-2343.
22. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20(4):1043-1048.
23. Baudhuin LM, Mai M, French AJ, et al. Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn. 2005;7(2):226-235.
24. Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42(6):491-496.
25. Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN. Evidence for auto-somal dominant inheritance of prostate cancer. Am J Hum Genet. 1998; 62(6):1425-1438
26. Curado MP, Edwards B, Shin HR, et al., eds. Cancer Incidence in Five Continents. Vol 9. Lyon, France: IARC; 2007. IARC Scientifc Publications No. 160.
27. Ewens WJ, Shute NC. Remarks on ascertainment. Genet Epidemiol. 1989;6(1):89-93.
28. Lange K, Cantor R, Horvath S, et al. Mendel version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet. 2001;69(suppl):A1886.
29. StataCorp. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP; 2007.
30. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116(6):1453-1456.
31. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6(1):105-110.
32. Senter L, Clendenning M, Sotamaa K, et al. The clinical phenotype of Lynch syndrome because of germ-line PMS2 mutations. Gastroenterology. 2008;135(2):419-428.
33. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296(12):1507-1517.
34. Hendriks YM, de Jong AE, Morreau H, et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006;56(4):213-225. (Pubitemid 44175050)
35. Renkonen-Sinisalo L, Butzow R, Leminen A, Lehtovirta P, Mecklin JP, Jarvinen HJ. Surveillance for endometrial cancer in hereditary nonpolypo-sis colorectal cancer syndrome. Int J Cancer. 2007;120(4):821-824.
36. U.S. Preventive Services Task Force. Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality; 2008. AHRQ Publication 08-05124-EF-3 http://www.ahrq.gov/clinic/uspstf08/colocancer/colors. htm. Accessed December 10 2008.
37. Visintin I, Feng Z, Longton G, et al. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res. 2008;14(4):1065-1072.
38. Myrhøj T, Andersen M-B, Bernstein I. Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer. Fam Cancer. 2008;7(4):303-307.